Research Analysts Issue Forecasts for Quantum-Si Q1 Earnings

Quantum-Si Incorporated (NASDAQ:QSI) – Research analysts at HC Wainwright issued their Q1 2026 EPS estimates for shares of Quantum-Si in a report issued on Friday, March 6th. HC Wainwright analyst S. Ramakanth forecasts that the company will earn ($0.12) per share for the quarter. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si’s Q2 2026 earnings at ($0.12) EPS, Q3 2026 earnings at ($0.13) EPS, Q4 2026 earnings at ($0.13) EPS and FY2030 earnings at $0.00 EPS.

Several other research firms have also weighed in on QSI. Weiss Ratings restated a “sell (d-)” rating on shares of Quantum-Si in a report on Monday, December 29th. Canaccord Genuity Group cut their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $3.25.

Quantum-Si Stock Down 3.9%

Quantum-Si stock opened at $0.87 on Monday. The firm has a fifty day moving average of $1.10 and a 200-day moving average of $1.37. Quantum-Si has a 52-week low of $0.84 and a 52-week high of $3.10. The firm has a market capitalization of $188.36 million, a P/E ratio of -1.68 and a beta of 3.00.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.06. Quantum-Si had a negative net margin of 4,160.06% and a negative return on equity of 43.90%. The firm had revenue of $0.45 million for the quarter, compared to analysts’ expectations of $0.76 million.

Insider Buying and Selling

In other news, CEO Jeffrey Alan Hawkins sold 23,707 shares of Quantum-Si stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total transaction of $30,344.96. Following the sale, the chief executive officer owned 2,578,018 shares in the company, valued at $3,299,863.04. This trade represents a 0.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider John S. Vieceli sold 21,927 shares of the company’s stock in a transaction on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total transaction of $28,066.56. Following the completion of the transaction, the insider owned 800,973 shares of the company’s stock, valued at $1,025,245.44. This trade represents a 2.66% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 54,261 shares of company stock worth $69,454 in the last quarter. Insiders own 22.95% of the company’s stock.

Hedge Funds Weigh In On Quantum-Si

A number of institutional investors have recently made changes to their positions in the business. Prudential Financial Inc. acquired a new stake in shares of Quantum-Si during the second quarter worth approximately $25,000. Cerity Partners LLC bought a new position in Quantum-Si during the 2nd quarter valued at $29,000. Capital Investment Advisory Services LLC boosted its stake in Quantum-Si by 100.0% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock valued at $28,000 after acquiring an additional 10,000 shares during the last quarter. Kingsview Wealth Management LLC grew its holdings in Quantum-Si by 99.9% during the 2nd quarter. Kingsview Wealth Management LLC now owns 20,012 shares of the company’s stock worth $39,000 after acquiring an additional 10,000 shares in the last quarter. Finally, Elite Life Management LLC bought a new stake in shares of Quantum-Si in the 3rd quarter worth about $29,000. 39.90% of the stock is owned by institutional investors and hedge funds.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.